CD74 and myeloid sarcoma: In early MS patients, B cells have been found to have downregulated MIF and MIF receptor (CD74) and upregulated the MIF receptor CXCR4 as compared to healthy controls, potentially reflecting a functional state of anergy that may contribute to the persistence of pathogenic immature B cells in the periphery [47].